Dr. Namita Singh leads Medical Affairs (MA) and Global Public Health (GPH) at BD, (Becton, Dickinson, and Company), a leading global medical technology company headquartered in Franklin Lakes, New Jersey. Dr Namita provides leadership and oversight to the South Asia MA & GPH organizations, playing a key role in driving compelling clinical and market shaping strategies to support improved healthcare outcomes.
Dr. Namita is an accomplished Healthcare leader with over 23 years of versatile experience across Corporate & Development sectors. She has strong expertise in Medical Affairs, Public Health, Market Shaping, Advocacy and Shaping Policies & Guidelines for best practice adoption and scaling up of innovative technologies and interventions for advancing healthcare. She actively engages with experts, key stakeholders/forums and policy makers to contribute thought and advocacy leadership to drive impact at scale. Dr Namita has successfully developed strong and highly talented MA & GPH teams for BD South Asia.
Prior to joining BD, she has worked in leadership positions with Clinton Health Access Initiative (CHAI) and SRL Clinical Reference Labs. She has led large-scale Global and National projects for CHAI in collaboration with the Ministry of Health and International partners. She has been a member of select National & International Technical Resource Groups (TRGs)/Committees and speaker at prestigious National and International forums.
Dr. Namita earned her MBBS and MD in Microbiology from Indira Gandhi Medical College Shimla, India.
In her free time, Namita loves to explore & travel and spend time with family and friends.
